Artículo

Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism

Miceli, Diego DanielIcon ; García, Jorge D.; Pompili, Gustavo A.; Rey Amunategui, Juan P.; Ferraris, Sergio; Pignataro, Omar PedroIcon ; Guitelman, Mirtha Adriana
Fecha de publicación: 02/2022
Editorial: Elsevier
Revista: Journal of Feline Medicine and Surgery
ISSN: 1098-612X
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

The aim of this study was to evaluate the safety and efficacy of cabergoline to control hypersomatotropism (HST) and diabetes mellitus (DM) in cats. This was a prospective cohort study. Twenty-three cats with HST and concurrent DM were enrolled. Cats received a dose of 10 μg/kg cabergoline q48h PO for 6 months. Serum insulin-like growth factor 1 (IGF-1) and fructosamine concentrations, insulin dose and Insulin Resistance Index (IRI) were measured at the time of diagnosis of HST and at the start of cabergoline treatment (t0), and 3 months (t1) and 6 months (t2) during cabergoline treatment.
Palabras clave: ACROMEGALY , CABERGOLINE , DIABETES MELLITUS REMISSION , INSULIN-LIKE GROWTH FACTOR 1
 
Archivos asociados
Tamaño: 275.7Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/restrictedAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/165305
URL: https://journals.sagepub.com/doi/10.1177/1098612X221074924?url_ver=Z39.88-2003&r
DOI: http://dx.doi.org/10.1177/1098612X221074924
Colecciones
Articulos(IBYME)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Citación
Miceli, Diego Daniel; García, Jorge D.; Pompili, Gustavo A.; Rey Amunategui, Juan P.; Ferraris, Sergio; et al.; Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism; Elsevier; Journal of Feline Medicine and Surgery; 144; 2-2022; 1-7
Compartir
Altmétricas